Quotes MaaT Pharma OTC Markets

Stocks

Market Closed - OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-

09-29	MaaT Pharma SA Reports Earnings Results for the Half Year Ended June 30, 2026	CI
09-21	MaaT Pharma Schedules Pre-IND Meeting with FDA and Advances MaaT034 Toward Clinical Development in Solid Tumors	CI

Stock exchange

OTC Markets MATPF - $ -.--% 0 $

Markets		Price	Change	Volumes
Euronext Paris	MAAT	1.030EUR	-4.98%	116K €
CBOE		1.022EUR	-7.09%	8.87K €
Deutsche Boerse AG	4RD	1.040EUR	-7.47%	0 €
Börse Stuttgart	4RD	0.9960EUR	-0.40%	0 €
Boerse Muenchen	4RD	1.050EUR	0.00%	0 €
CBOE		5.240EUR	0.00%	0 €

markets

Capital turnover ratio

Float rotation

Market Cap (USD)

21,852,012

Net sales (EUR)

4,524,000

Net sales (USD)

5,093,447

Number of employees

Sales / Employee (EUR)

80,786

Sales / Employee (USD)

90,954

Free-Float

36.85%

Free-Float capitalization (USD)

8,055,140

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
MAAT PHARMA	-.--%	-.--%	-	-	21.85M
WUXI APPTEC CO., LTD.	+4.16%	+3.04%	+49.37%	+94.17%	74.41B
ARGENX SE	-0.61%	+0.81%	+27.25%	+82.72%	59.26B
LONZA GROUP AG	-2.54%	-1.65%	+4.86%	+31.72%	47.14B
IQVIA HOLDINGS INC.	-3.02%	-5.20%	+27.94%	+32.51%	42.91B
REVOLUTION MEDICINES, INC.	+0.31%	+3.02%	+348.95%	+643.82%	44.13B
BEONE MEDICINES AG	-1.96%	-0.33%	+7.04%	+99.46%	40.79B
CELLTRION, INC.	+3.32%	+3.49%	+10.10%	+51.23%	30.77B
WUXI BIOLOGICS (CAYMAN) INC.	-2.94%	+2.45%	+29.04%	+22.16%	29.31B
INSMED INCORPORATED	-4.86%	-10.66%	-26.27%	+330.06%	23.71B
Average	-0.83%	-0.52%	+53.14%	+154.21%	39.25B
Weighted average by Cap.	-0.37%	-0.32%	+58.46%	+146.06%